{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:23:49Z","timestamp":1791861829110,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1998,8,1]],"date-time":"1998-08-01T00:00:00Z","timestamp":901929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[1998,8]]},"DOI":"10.1006\/gyno.1998.5087","type":"journal-article","created":{"date-parts":[[2002,10,7]],"date-time":"2002-10-07T14:25:03Z","timestamp":1034000703000},"page":"188-191","source":"Crossref","is-referenced-by-count":14,"title":["Steroid Receptor Expression in Endometria from Women Treated with Tamoxifen"],"prefix":"10.1006","volume":"70","author":[{"given":"Friedrich","family":"Kommoss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Karck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Pr\u00f6mpeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus","family":"Pfisterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles James","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.1998.5087_GO985087RF1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0140-6736(85)90966-3","article-title":"Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high estrogen receptor levels","volume":"1","author":"Rose","year":"1985","journal-title":"Lancet"},{"key":"10.1006\/gyno.1998.5087_GO985087RF2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000225571","article-title":"Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients","volume":"38","author":"Boccardo","year":"1981","journal-title":"Oncology"},{"key":"10.1006\/gyno.1998.5087_GO985087RF3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0002-9378(92)91854-4","article-title":"Rapid growth of leiomyoma in patients receiving tamoxifen","volume":"166","author":"Dilts","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.1998.5087_GO985087RF4","first-page":"119","article-title":"Tamoxifen-induced growth of leiomyomas","volume":"41","author":"Kang","year":"1996","journal-title":"J Reprod Med"},{"key":"10.1006\/gyno.1998.5087_GO985087RF5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1471-0528.1990.tb02557.x","article-title":"Tamoxifen and endometriosis: case report","volume":"97","author":"Buckley","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1006\/gyno.1998.5087_GO985087RF6","first-page":"642","article-title":"Intestinal and pelvic endometriosis presenting as a tumor and associated with tamoxifen therapy: report of a case","volume":"82","author":"Hajjar","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.1998.5087_GO985087RF7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1055\/s-2007-1023333","article-title":"Endometriose unter Tamoxifentherapie","volume":"55","author":"Fuith","year":"1995","journal-title":"Geburtsh Frauenheilk"},{"key":"10.1006\/gyno.1998.5087_GO985087RF8","first-page":"660","article-title":"Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen","volume":"81","author":"Lahti","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.1998.5087_GO985087RF9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","article-title":"Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers","volume":"i","author":"Fornander","year":"1989","journal-title":"Lancet"},{"key":"10.1006\/gyno.1998.5087_GO985087RF10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0020-7292(91)90767-Y","article-title":"Endometrial lesions in patients undergoing tamoxifen therapy","volume":"36","author":"De Muylder","year":"1990","journal-title":"Int J Gynecol Obstet"},{"key":"10.1006\/gyno.1998.5087_GO985087RF11","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/jnci\/83.14.1013","article-title":"Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer","volume":"83","author":"Andersson","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.1998.5087_GO985087RF12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0140-6736(93)91590-I","article-title":"Tamoxifen and endometrial lesions","volume":"342","author":"Neven","year":"1993","journal-title":"Lancet"},{"key":"10.1006\/gyno.1998.5087_GO985087RF13","first-page":"3362","article-title":"Immunhistochemischer Nachweis von \u00d6strogenrezeptoren (ER-ICA) in Mammakarzinomgewebe: Vorschlag zur einheitlichen Formulierung des Untersuchungsbefundes","volume":"83","author":"Remmele","year":"1986","journal-title":"Deutsches \u00c4rtzeblatt"},{"key":"10.1006\/gyno.1998.5087_GO985087RF14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0090-8258(92)90133-4","article-title":"Steroid receptors in ovarian carcinoma: immunohistochemical determination may lead to new aspects","volume":"47","author":"Kommoss","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.1998.5087_GO985087RF15","first-page":"203","article-title":"Steroid receptors in carcinoma of the breast. Results of immunocytochemical and biochemical determination and their effects on short-term prognosis","volume":"16","author":"Kommoss","year":"1994","journal-title":"Anal Quant Cytol Histol"},{"key":"10.1006\/gyno.1998.5087_GO985087RF16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004347-199501000-00003","article-title":"Mucinous and clear cell adenocarcinomas of the endometrium in patients receiving antiestrogens (tamoxifen) and gestagens","volume":"14","author":"Dallenbach-Hellweg","year":"1995","journal-title":"Int J Gynecol Pathol"},{"key":"10.1006\/gyno.1998.5087_GO985087RF17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0090-8258(91)90330-8","article-title":"Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer\u2014preliminary report","volume":"42","author":"Gal","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.1998.5087_GO985087RF18","first-page":"812","article-title":"Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse","volume":"48","author":"Gottardis","year":"1988","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.1998.5087_GO985087RF19","first-page":"2362","article-title":"Stimulatory effects of 4-hydroxy tamoxifen on proliferation of human endometrial adenocarcinoma cells (Ishikawa line)","volume":"49","author":"Anzai","year":"1989","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.1998.5087_GO985087RF20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0022-4731(75)90179-X","article-title":"Oestrogen induced progesterone receptor in human uterus","volume":"6","author":"Janne","year":"1975","journal-title":"J Steroid Biochem"},{"key":"10.1006\/gyno.1998.5087_GO985087RF21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1993.11.3.485","article-title":"High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients","volume":"11","author":"Magriples","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1998.5087_GO985087RF22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/gyno.1994.1271","article-title":"Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features","volume":"55","author":"Barakat","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.1998.5087_GO985087RF23","first-page":"28","article-title":"Status of antiestrogen breast cancer prevention trials","volume":"12","author":"Powles","year":"1998","journal-title":"Oncology (Hunting+)"},{"key":"10.1006\/gyno.1998.5087_GO985087RF24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nm0496-381","article-title":"Tamoxifen: teaching an old drug new tricks","volume":"2","author":"Grainger","year":"1996","journal-title":"Nature Medicine"},{"key":"10.1006\/gyno.1998.5087_GO985087RF25","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2058::AID-CNCR14>3.0.CO;2-U","article-title":"Endometrial carcinoma associated with breast cancer","volume":"77","author":"Cuenca","year":"1996","journal-title":"Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825898950879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825898950879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T05:25:58Z","timestamp":1557206758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825898950879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["S0090825898950879"],"URL":"https:\/\/doi.org\/10.1006\/gyno.1998.5087","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}